Stratrix
On the Record · Balchem

Balchem acquisitions, on the record

The businesses Balchem bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

BusinessDealWhenValue
Cardinal Associates Inc. (Bergstrom Nutrition)
Word for word“On August 30, 2022, the Company's wholly-owned subsidiary Albion Laboratories, Inc. ("Albion") entered into a Stock Purchase Agreement, and closed on such transaction with Cardinal Associates Inc. ("Cardinal"), a corporation organized under the laws of the State of Washington, pursuant to which Albion acquired Cardinal and its Bergstrom Nutrition business (collectively, "Bergstrom").” 10-K for 2023
acquisitionOn August 30, 2022—
Kechu BidCo AS and its subsidiary companies (Kappa)
Word for word“On June 21, 2022, the Company and its wholly-owned subsidiary, Balchem B.V., completed the acquisition of Kechu BidCo AS and its subsidiary companies, including Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway (all acquired companies collectively referred to as "Kappa").” 10-K for 2023
acquisitionOn June 21, 2022—
Kechu BidCo AS and its subsidiary companies, including Kappa Bioscience AS (Kappa)
Word for word“On June 21, 2022, the Company and its wholly-owned subsidiary, Balchem B.V., completed the acquisition of Kechu BidCo AS and its subsidiary companies, including Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway (all acquired companies collectively referred to as "Kappa").” 10-K for 2024
acquisitionOn June 21, 2022—
an existing toll manufacturer
Word for word“Cash paid to acquire an existing toll manufacturer to add capacity amounted to $24,164 for the year ended December 31, 2024, net of cash acquired.” 10-K for 2024
acquisitionfor the year ended December 31, 2024$24,164
Verona, Missouri facility
Word for word“We are indemnified by the sellers under our May 2001 asset purchase agreement covering our acquisition of the Verona, Missouri facility for potential liabilities associated with the Superfund site, and one of the sellers, in turn, has the benefit of certain contractual indemnification by Syntex in relation to the implementation of the above-described Superfund remedy.” 10-K for 2025
acquisitionMay 2001—
As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year endedCash paid for acquisitions (net of cash acquired)Goodwill from acquisitions
2016-12-31$110.6 million$55.9 million
2017-12-31$17.4 million$1.6 million
2018-12-31$17.4 million$6.8 million
2019-12-31$141.1 million$77.4 million
2020-12-31$0$432,000
2021-12-31$0—
2022-12-31$365.8 million—
2023-12-31$1.3 million$341,000
2024-12-31$24.2 million$19.4 million
2025-12-31$323,000$823,000

Deal filings since 2016

Read from Balchem’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.